Single-dose Study of ANX007 in Participants With Primary Open-angle Glaucoma
NCT03488550
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
9
Enrollment
INDUSTRY
Sponsor class
Conditions
Open-angle Glaucoma
Interventions
BIOLOGICAL:
ANX007
Sponsor
Annexon, Inc.